Literature DB >> 32590438

A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration.

Melanie Alufandika1,2, David S Lawrence3,4, Timothée Boyer-Chammard5,6, Cecilia Kanyama7, Chiratidzo E Ndhlovu8, Mosepele Mosepele4,9, Lillian Tugume10, David Meya10,11, David R Boulware11, Joshua Rhein10,11, Conrad Muzoora12, Nabila Youssouf3,4, Síle F Molloy13,14, Charlotte Schutz14,15, Olivier Lortholary5,6, Graeme Meintjes14,15, Henry C Mwandumba1,16, Thomas S Harrison13, Joseph N Jarvis3,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32590438      PMCID: PMC7473821          DOI: 10.1097/QAD.0000000000002556

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.632


× No keyword cloud information.
  18 in total

1.  Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.

Authors:  Radha Rajasingham; Rachel M Smith; Benjamin J Park; Joseph N Jarvis; Nelesh P Govender; Tom M Chiller; David W Denning; Angela Loyse; David R Boulware
Journal:  Lancet Infect Dis       Date:  2017-05-05       Impact factor: 25.071

2.  Outcomes of cryptococcal meningitis in antiretroviral naïve and experienced patients in South Africa.

Authors:  Joseph N Jarvis; Graeme Meintjes; Thomas S Harrison
Journal:  J Infect       Date:  2010-03-20       Impact factor: 6.072

Review 3.  Genetic barrier to resistance for dolutegravir.

Authors:  Josep M Llibre; Federico Pulido; Federico García; Miguel García Deltoro; José L Blanco; Rafael Delgado
Journal:  AIDS Rev       Date:  2015 Jan-Mar       Impact factor: 2.500

4.  Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.

Authors:  David R Boulware; David B Meya; Conrad Muzoora; Melissa A Rolfes; Katherine Huppler Hullsiek; Abdu Musubire; Kabanda Taseera; Henry W Nabeta; Charlotte Schutz; Darlisha A Williams; Radha Rajasingham; Joshua Rhein; Friedrich Thienemann; Melanie W Lo; Kirsten Nielsen; Tracy L Bergemann; Andrew Kambugu; Yukari C Manabe; Edward N Janoff; Paul R Bohjanen; Graeme Meintjes
Journal:  N Engl J Med       Date:  2014-06-26       Impact factor: 91.245

5.  Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.

Authors:  Síle F Molloy; Cecilia Kanyama; Robert S Heyderman; Angela Loyse; Charles Kouanfack; Duncan Chanda; Sayoki Mfinanga; Elvis Temfack; Shabir Lakhi; Sokoine Lesikari; Adrienne K Chan; Neil Stone; Newton Kalata; Natasha Karunaharan; Kate Gaskell; Mary Peirse; Jayne Ellis; Chimwemwe Chawinga; Sandrine Lontsi; Jean-Gilbert Ndong; Philip Bright; Duncan Lupiya; Tao Chen; John Bradley; Jack Adams; Charles van der Horst; Joep J van Oosterhout; Victor Sini; Yacouba N Mapoure; Peter Mwaba; Tihana Bicanic; David G Lalloo; Duolao Wang; Mina C Hosseinipour; Olivier Lortholary; Shabbar Jaffar; Thomas S Harrison
Journal:  N Engl J Med       Date:  2018-03-15       Impact factor: 91.245

6.  Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART Initiation.

Authors:  Joshua Rhein; Kathy H Hullsiek; Emily E Evans; Lillian Tugume; Edwin Nuwagira; Kenneth Ssebambulidde; Reuben Kiggundu; Edward Mpoza; Abdu K Musubire; Ananta S Bangdiwala; Nathan C Bahr; Darlisha A Williams; Mahsa Abassi; Conrad Muzoora; David B Meya; David R Boulware
Journal:  Open Forum Infect Dis       Date:  2018-05-24       Impact factor: 3.835

7.  AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.

Authors:  David S Lawrence; Nabila Youssouf; Síle F Molloy; Alexandre Alanio; Melanie Alufandika; David R Boulware; Timothée Boyer-Chammard; Tao Chen; Francoise Dromer; Admire Hlupeni; William Hope; Mina C Hosseinipour; Cecilia Kanyama; Oliver Lortholary; Angela Loyse; David B Meya; Mosepele Mosepele; Conrad Muzoora; Henry C Mwandumba; Chiratidzo E Ndhlovu; Louis Niessen; Charlotte Schutz; Katharine E Stott; Duolao Wang; David G Lalloo; Graeme Meintjes; Shabbar Jaffar; Thomas S Harrison; Joseph N Jarvis
Journal:  Trials       Date:  2018-11-23       Impact factor: 2.279

8.  High Mortality in HIV-Associated Cryptococcal Meningitis Patients Treated With Amphotericin B-Based Therapy Under Routine Care Conditions in Africa.

Authors:  Raju K K Patel; Tshepo Leeme; Caitlin Azzo; Nametso Tlhako; Katlego Tsholo; Ephraim O Tawanana; Mooketsi Molefi; Mosepele Mosepele; David S Lawrence; Margaret Mokomane; Mark W Tenforde; Joseph N Jarvis
Journal:  Open Forum Infect Dis       Date:  2018-10-23       Impact factor: 3.835

Review 9.  Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.

Authors:  Ingrid Eshun-Wilson; Mbah P Okwen; Marty Richardson; Tihana Bicanic
Journal:  Cochrane Database Syst Rev       Date:  2018-07-24

10.  Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy-Experienced Ugandans With Virologic Failure.

Authors:  Edward Mpoza; Radha Rajasingham; Lillian Tugume; Joshua Rhein; Maria Sarah Nabaggala; Isaac Ssewanyana; Wilson Nyegenye; Grace Esther Kushemererwa; Vivienne Mulema; Julius Kalamya; Charles Kiyaga; Joseph Kabanda; Mina Ssali; David R Boulware; David B Meya
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 9.079

View more
  3 in total

1.  Cryptococcal and Histoplasma Antigen Screening Among People With Human Immunodeficiency Virus in Ghana and Comparative Analysis of OIDx Histoplasma Lateral Flow Assay and IMMY Histoplasma Enzyme Immunoassay.

Authors:  Bright K Ocansey; Benjamin Otoo; Isabella Asamoah; Vincent Ganu; Kofi P Berko; Oluwakemi Oladele; Emmanuella A Amankwa; Bismark Opoku-Asare; Martin Agyei; Lawrence George; Fleischer C N Kotey; Chris Kosmidis; Peter Puplampu; Japheth A Opintan; David W Denning
Journal:  Open Forum Infect Dis       Date:  2022-06-03       Impact factor: 4.423

2.  Short-term Mortality Outcomes of HIV-Associated Cryptococcal Meningitis in Antiretroviral Therapy-Naïve and -Experienced Patients in Sub-Saharan Africa.

Authors:  Newton Kalata; Jayne Ellis; Cecilia Kanyama; Charles Kuoanfank; Elvis Temfack; Sayoki Mfinanga; Sokoine Lesikari; Duncan Chanda; Shabir Lakhi; Tinashe Nyazika; Adrienne K Chan; Joep J van Oosterhout; Tao Chen; Mina C Hosseinipour; Olivier Lortholary; Duolao Wang; Shabbar Jaffar; Angela Loyse; Robert S Heyderman; Thomas S Harrison; Síle F Molloy
Journal:  Open Forum Infect Dis       Date:  2021-07-28       Impact factor: 4.423

3.  High Burden of Cryptococcal Meningitis Among Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-Infected Patients in Northern Uganda in the Era of "Test and Treat": Implications for Cryptococcal Screening Programs.

Authors:  Mark Okwir; Abigail Link; Joshua Rhein; John Stephen Obbo; James Okello; Betty Nabongo; Jimmy Alal; David Meya; Paul R Bohjanen
Journal:  Open Forum Infect Dis       Date:  2022-01-10       Impact factor: 3.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.